Orion Portfolio Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.87M Buy
34,672
+1,051
+3% +$112K 0.04% 429
2024
Q4
$3.27M Buy
33,621
+1,198
+4% +$128K 0.03% 471
2024
Q3
$3.73M Buy
32,423
+1,079
+3% +$122K 0.04% 422
2024
Q2
$3.34M Buy
31,344
+1,976
+7% +$198K 0.04% 427
2024
Q1
$2.84M Sell
29,368
-587
-2% -$60.2K 0.03% 506
2023
Q4
$3.21M Sell
29,955
-1,914
-6% -$185K 0.04% 431
2023
Q3
$3.25M Sell
31,869
-59
-0.2% -$5.99K 0.04% 404
2023
Q2
$3.22M Buy
31,928
+3,088
+11% +$309K 0.03% 455
2023
Q1
$2.65M Buy
+28,840
New +$2.52M 0.03% 477
2020
Q3
Sell
-408
Closed -$36K 1506
2020
Q2
$36K Sell
408
-234
-36% -$20.2K ﹤0.01% 785
2020
Q1
$53K Buy
642
+293
+84% +$26.1K ﹤0.01% 580
2019
Q4
$33K Buy
+349
New +$31.3K ﹤0.01% 644

Other funds holding NVS

Orion Portfolio Solutions's NVS Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Novartis (NVS) stake by 3.1% in Q1 2025, buying an estimated $112K and bringing the position to 34,672 shares worth $3.87M. The position accounts for 0.04% of the portfolio, ranked #429.

Orion Portfolio Solutions first reported a position in NVS in Q4 2019 and has held it in 12 quarters since. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Orion Portfolio Solutions held 34,672 shares of Novartis worth $3.87M as of Q1 2025.
  • Orion Portfolio Solutions bought 1,051 Novartis shares in Q1 2025, an estimated $112K.
  • Novartis made up 0.04% of Orion Portfolio Solutions's portfolio in Q1 2025, its #429 holding.
  • Orion Portfolio Solutions first reported a position in Novartis in Q4 2019 and has held it in 12 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.